Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in European Urology Oncology
- Vol. 3 (4) , 420-423
Abstract
No abstract availableKeywords
Funding Information
- Decipher Biosciences
This publication has 10 references indexed in Scilit:
- Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversionCurrent Opinion in Urology, 2019
- Molecular landscape of carcinoma invading bladder muscle: does patient age matter?BJU International, 2019
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder CancerCell, 2018
- Gender Specific Differences in Disease-Free, Cancer Specific and Overall Survival after Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-AnalysisJournal of Urology, 2018
- Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerNature Communications, 2017
- Comprehensive Characterization of Molecular Differences in Cancer between Male and Female PatientsCancer Cell, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systemsBMC Medical Genomics, 2015
- Constitutive β-Catenin Activation Induces Male-Specific Tumorigenesis in the Bladder UrotheliumCancer Research, 2013
- Sex and racial differences in bladder cancer presentation and mortality in the USCancer, 2008